"Through a blend of gentle compassion and state-of-the-art oncology care, we're committed to offering you the best medical and emotional support possible."

During the past decade, Mile High Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mile High Oncology" #1 sponsor was "Point Therapeutics" with 2 trials, followed by "Astex Pharmaceuticals, Inc." with 1 trials sponsored, "East Valley Hematology and Oncology Medical Group" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mile High Oncology" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mile High Oncology" are "Pancreatic Cancer" (2 trials), "Carcinoma, Non-Small Cell Lung" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Carcinoma, Squamous Cell" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Mile High Oncology" in a lesser frequency.

Most popular intervention types in "Mile High Oncology" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Glufosfamide" (1 trials), "Nipent, Cytoxan, Rituxan" (1 trials), "Proxinium" (1 trials), "Rubitecan" (1 trials) and "Vatalanib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mile High Oncology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Mile High Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mile High Oncology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mile High Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".